Sign in
8-K

Current Report

Serina Therapeutics, Inc. Filed Acc 0001493152-20-007466

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading form8-k.htm…